(25) identified key microRNAs and hub genes associated with poor prognosis in lung adenocarcinoma via miRNA-mRNA network, they indicated that PECAM1, in particular, may be a novel biomarker of survival that provided a novel diagnostic biomarkers and therapeutic targets for the treatment of LUAD. The gene discussed is PECAM1; the disease is lung adenocarcinoma.